Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Brivaracetam in Focal Epilepsy
CTR20210945Phase 3Completed
- Sponsor
- UCB
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in Focal Onset Epilepsy, focal to bilateral tonic-clonic seizure, sponsored by UCB. Started May 2021; status: completed.
02
Drugs
brivaracetam
03
Conditions
Focal Onset Epilepsyfocal to bilateral tonic-clonic seizure
Beyond the preview
Go deeper on CTR20210945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210945.